http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005075670-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f81c6fa05269fed8e8665a8e72778ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c638b3d53f08704b0e690dd56aed463a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7762bde0f09a3532b192350faf60dd76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d65404d7ce4256fc644301a0d6c0bd7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_183aeabfde9cb281e2846cb0a801e79f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-90238
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-56
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-26
filingDate 2005-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e562931001baac2f5f8efa70c57bb5a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34f0157f4e8b62de3e0c9fff9b31166a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_977fead862dbad30fed4014054f6bef9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54ed0f184ac15a19e90666b116c353b0
publicationDate 2005-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2005075670-A2
titleOfInvention A method of detecting enzyme inhibitor resistance in individuals
abstract A method of detecting in an individual incomplete inhibition an enzyme involved in thrombus formation, especially platelet cyclooxygesane, is described. The method comprises the steps of obtaining from the individual a biological sample which contains the enzyme, adding an exogenous substrate for the enzyme to the sample to form a reaction mixture, and assaying the reaction mixture for any increase in a level of a metabolite of the enzyme. The method is especially suitable for detecting sub-optimal ASPIRIN inhibition in individuals undergoing ASPIRIN anti-thrombosis therapy. Kits for carrying out the method of the invention are also described.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102008022189-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015160712-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10041105-B2
priorityDate 2004-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0420332-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002106707-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423826
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415816644
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID443551
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID282022
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID19224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5283137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395791
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6224
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373926
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81070
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5312542
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22833565
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444899
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100009407
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22775
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411625
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414784756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414940547
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP84122
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431577138
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID246226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585247
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6335613
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406377
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129952113
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513456
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403544
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229481086
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3672
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280891
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406378
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90470996
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID464713
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68654313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409206349
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129205760
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24693
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5742
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID114873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226815826
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4947
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6049
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395837
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395818
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395293

Total number of triples: 83.